Home › Employers › Ascend Advanced Therapies FL Inc.
Ascend Advanced Therapies FL Inc.: H-1B salaries and sponsorship
Ascend Advanced Therapies FL Inc. filed 3 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $103,043.
Does Ascend Advanced Therapies FL Inc. sponsor H-1B visas?
Ascend Advanced Therapies FL Inc. filed 3 labor condition applications in fiscal years 2023–2026, the latest submitted on May 15, 2026. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.
Salaries by job title
| Job title | LCAs | Median salary |
|---|---|---|
| Process Development Engineer III | 1 | $95,326 |
| Manager, Process Development - Assay Development | 1 | $103,043 |
| Chief Executive Officer | 1 | $279,885 |
Applications by fiscal year
| Fiscal year | LCAs | Median salary |
|---|---|---|
| FY2024 | 2 | $99,184 |
| FY2026 | 1 | $279,885 |
Prevailing wage levels
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Where the jobs are
Occupations
Latest applications
| Job title | Base salary | Location | Submitted | Start date | Status |
|---|---|---|---|---|---|
| Chief Executive Officer | $279,885 Level IV | Alachua, FL | May 15, 2026 | Oct 1, 2026 | Certified |
| Process Development Engineer III | $95,326 Level IV | Alachua, FL | Jun 10, 2024 | Jun 17, 2024 | Certified |
| Manager, Process Development - Assay Development | $103,043 Level III | Alachua, FL | Apr 16, 2024 | May 1, 2024 | Certified |
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).